US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

This Week's Healthcare Earnings: Elevance, HCA And More No Photo Available

Yeji Jesse Lee

Some of the biggest companies in the healthcare industry posted their first-quarter results this past week. Here's what you need to know.

As RFK Jr. Touts Peptides, Industry Eyes Regulatory Hurdles No Photo Available

Dan McKay

Compounding pharmacies eager to cash in on the peptide boom are watching closely as the nation’s top health official pushes to legaliz... (more story)

Attys Want To See Examples In New Mental Health Parity Rule No Photo Available

Kellie Mejdrich

The Trump administration's plans to promulgate new regulations governing mental health parity requirements for employee health plans a... (more story)